To Evaluate the Efficacy and Safety of Pegozafermin in Subjects With Severe Hypertriglyceridemia

Clinical trial NCT05852431 · COMPLETED

Trial details

NCT number: NCT05852431
Sponsor: 89bio, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Severe Hypertriglyceridemia

Start date: 2023-06-15
Primary completion: 2025-07-07
Enrollment: 369

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.